196 related articles for article (PubMed ID: 27933411)
1. Society of Surgical Oncology Breast Disease Working Group Statement on Prophylactic (Risk-Reducing) Mastectomy.
Hunt KK; Euhus DM; Boughey JC; Chagpar AB; Feldman SM; Hansen NM; Kulkarni SA; McCready DR; Mamounas EP; Wilke LG; Van Zee KJ; Morrow M
Ann Surg Oncol; 2017 Feb; 24(2):375-397. PubMed ID: 27933411
[TBL] [Abstract][Full Text] [Related]
2. Should the use of contralateral prophylactic mastectomy be increasing as it is?
Wood WC
Breast; 2009 Oct; 18 Suppl 3():S93-5. PubMed ID: 19914552
[TBL] [Abstract][Full Text] [Related]
3. Contralateral Prophylactic Mastectomy: Challenging Considerations for the Surgeon.
Angelos P; Bedrosian I; Euhus DM; Herrmann VM; Katz SJ; Pusic A
Ann Surg Oncol; 2015 Oct; 22(10):3208-12. PubMed ID: 26259752
[TBL] [Abstract][Full Text] [Related]
4. Discussions about contralateral prophylactic mastectomy among surgical oncology providers and women with sporadic breast cancer: a content analysis.
D'Agostino TA; Brewster AM; Peterson SK; Bedrosian I; Parker PA
Transl Behav Med; 2020 May; 10(2):347-354. PubMed ID: 30561744
[TBL] [Abstract][Full Text] [Related]
5. The development of a template for psychological assessment of women considering risk-reducing or contralateral prophylactic mastectomy: A national Delphi consensus study.
Braude L; Kirsten L; Gilchrist J; Juraskova I
Psychooncology; 2018 Oct; 27(10):2349-2356. PubMed ID: 29966172
[TBL] [Abstract][Full Text] [Related]
6. Streamlining Decision Making in Contralateral Risk-Reducing Mastectomy: Impact of PREDICT and BOADICEA Computations.
de Silva TS; Russell VR; Henry FP; Thiruchelvam PTR; Hadjiminas DJ; Al-Mufti R; Hogben RK; Hunter J; Wood S; Jallali N; Leff DR
Ann Surg Oncol; 2018 Oct; 25(10):3057-3063. PubMed ID: 30019305
[TBL] [Abstract][Full Text] [Related]
7. Predictors of contralateral prophylactic mastectomy and the impact on breast reconstruction.
Pinell-White XA; Kolegraff K; Carlson GW
Ann Plast Surg; 2014; 72(6):S153-7. PubMed ID: 24691345
[TBL] [Abstract][Full Text] [Related]
8. The contralateral prophylactic mastectomy decision-making process.
Baker SK; Mayer DK; Esposito N
Plast Surg Nurs; 2013; 33(1):11-21; quiz 22-3. PubMed ID: 23446503
[TBL] [Abstract][Full Text] [Related]
9. Exploring reasons for overuse of contralateral prophylactic mastectomy in Canada.
Squires JE; Simard SN; Asad S; Stacey D; Graham ID; Coughlin M; Clemons M; Grimshaw JM; Zhang J; Caudrelier JM; Arnaout A
Curr Oncol; 2019 Aug; 26(4):e439-e457. PubMed ID: 31548812
[TBL] [Abstract][Full Text] [Related]
10. Prophylactic mastectomy for the prevention of breast cancer.
Lostumbo L; Carbine N; Wallace J; Ezzo J
Cochrane Database Syst Rev; 2004 Oct; (4):CD002748. PubMed ID: 15495033
[TBL] [Abstract][Full Text] [Related]
11. Mastectomy for risk reduction or symmetry in women without high risk gene mutation: A review.
Kenny R; Reed M; Subramanian A
Int J Surg; 2018 Feb; 50():60-64. PubMed ID: 29288115
[TBL] [Abstract][Full Text] [Related]
12. Is prophylactic mastectomy justified in women without BRCA mutation?
Rutgers EJT
Breast; 2019 Nov; 48 Suppl 1():S62-S64. PubMed ID: 31839163
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of prophylactic mastectomy in women with unilateral breast cancer: a cancer research network project.
Herrinton LJ; Barlow WE; Yu O; Geiger AM; Elmore JG; Barton MB; Harris EL; Rolnick S; Pardee R; Husson G; Macedo A; Fletcher SW
J Clin Oncol; 2005 Jul; 23(19):4275-86. PubMed ID: 15795415
[TBL] [Abstract][Full Text] [Related]
14. Reframing the conversation about contralateral prophylactic mastectomy: Preparing women for postsurgical realities.
Bloom DL; Chapman BM; Wheeler SB; McGuire KP; Lee CN; Weinfurt K; Rosenstein DL; Plichta JK; Jacobson Vann JC; Hwang ES
Psychooncology; 2019 Feb; 28(2):394-400. PubMed ID: 30500102
[TBL] [Abstract][Full Text] [Related]
15. Assessing the Effect of Lifetime Contralateral Breast Cancer Risk on the Selection of Contralateral Prophylactic Mastectomy for Unilateral Breast Cancer.
Hegde JV; Wang X; Attai DJ; DiNome ML; Kusske A; Hoyt AC; Hurvitz SA; Weidhaas JB; Steinberg ML; McCloskey SA
Clin Breast Cancer; 2018 Apr; 18(2):e205-e218. PubMed ID: 29050918
[TBL] [Abstract][Full Text] [Related]
16. Contralateral risk-reducing mastectomy in young women.
Merck B
Breast Cancer Res Treat; 2010 Sep; 123 Suppl 1():29-32. PubMed ID: 20711671
[No Abstract] [Full Text] [Related]
17. Factors associated with decision to undergo contralateral prophylactic mastectomy versus unilateral mastectomy.
Huang J; Chagpar A
Am J Surg; 2019 Jul; 218(1):170-174. PubMed ID: 30554666
[TBL] [Abstract][Full Text] [Related]
18. Contralateral prophylactic mastectomy for patients with unilateral breast cancer.
Tuttle T; Habermann E; Abraham A; Emory T; Virnig B
Expert Rev Anticancer Ther; 2007 Aug; 7(8):1117-22. PubMed ID: 18028020
[TBL] [Abstract][Full Text] [Related]
19. Prophylactic mastectomy: who needs it, when and why.
Burke EE; Portschy PR; Tuttle TM
J Surg Oncol; 2015 Jan; 111(1):91-5. PubMed ID: 24965368
[TBL] [Abstract][Full Text] [Related]
20. "It felt like unfinished business, it feels like that's finished now": Women's experiences of decision making around contralateral prophylactic mastectomy (CPM).
Tollow P; Williams VS; Harcourt D; Paraskeva N
Psychooncology; 2019 Jun; 28(6):1328-1334. PubMed ID: 30963646
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
